PGP and breast carcinoma: In spite of the long half-life of P-gp (5–17 hrs)18 transient transfections of siRNA could selectively reduce P-gp in overexpressing Caco-2 cells18 and to a greater extent (around 65%) in drug-resistant human breast cancer cells MCF-7/AdrR with an enhanced drug sensitivity19.